Weyer Christian 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Apr 3, 2020
Insider Transaction Report
Form 4
Weyer Christian
EVP Research and Development
Transactions
- Tax Payment
Common Stock
2020-04-01$58.40/sh−46$2,686→ 17,321 total
Footnotes (1)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.